Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2019

Mar 4, 2019

3535_iss_2019-03-04_f3a28b89-6918-43b9-ac59-c52bfac521c1.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Aqua Bio Technology Asa – Result of Subsequent Offering

Aqua Bio Technology Asa – Result of Subsequent Offering

Reference is made to the stock exchange notice by Aqua Bio Technology ASA (the

"Company") on 4 December 2018 and 12 February 2019 regarding, inter alia, a

private placement (the "Private Placement") and a following subsequent offering

with gross proceeds of up to NOK 551,250 through issuance of new shares at a

subscription price of NOK 2.50 per share (the "Subsequent Offering"). The

investors in the Subsequent Offering will also receive one (1) warrant per share

applied for and allocated in the Subsequent Offering.

The application period in the Subsequent Offering ended on 28 February 2019 at

16.30 CET. At the end of the application period, the Company had received

applications of approximately NOK 302,240 in the Subsequent Offering through

subscription of 120,896 new shares.

The Company`s board of directors (the "Board") has now allocated shares and

warrants in the Subsequent Offering, which implies that the Company will issue

120,896 new shares and 120,896 new warrants related to the Subsequent Offering.

Allocation letters, regarding the number of shares and warrants allocated and

the subscription amount to be paid, will be distributed to the subscribers

shortly.

For further information, please call Arvid Lindberg, head of Sales & Marketing,

telephone +47 98245410 or [email protected] (mailto:[email protected]).

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT`s cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqya Bio Technology is listed on the Axess market of the

Oslo Stock Exchange.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

??